Logo image of VANI

VIVANI MEDICAL INC (VANI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VANI - US92854B1098 - Common Stock

1.34 USD
+0.01 (+0.75%)
Last: 12/2/2025, 4:30:02 PM
Fundamental Rating

1

Overall VANI gets a fundamental rating of 1 out of 10. We evaluated VANI against 188 industry peers in the Health Care Equipment & Supplies industry. While VANI seems to be doing ok healthwise, there are quite some concerns on its profitability. VANI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VANI has reported negative net income.
In the past year VANI has reported a negative cash flow from operations.
In the past 5 years VANI always reported negative net income.
In the past 5 years VANI always reported negative operating cash flow.
VANI Yearly Net Income VS EBIT VS OCF VS FCFVANI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -88.35%, VANI is not doing good in the industry: 77.66% of the companies in the same industry are doing better.
VANI's Return On Equity of -520.10% is on the low side compared to the rest of the industry. VANI is outperformed by 82.98% of its industry peers.
Industry RankSector Rank
ROA -88.35%
ROE -520.1%
ROIC N/A
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VANI Yearly ROA, ROE, ROICVANI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

VANI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VANI Yearly Profit, Operating, Gross MarginsVANI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, VANI has more shares outstanding
VANI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for VANI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VANI Yearly Shares OutstandingVANI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
VANI Yearly Total Debt VS Total AssetsVANI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -7.11, we must say that VANI is in the distress zone and has some risk of bankruptcy.
VANI has a Altman-Z score of -7.11. This is in the lower half of the industry: VANI underperforms 71.81% of its industry peers.
There is no outstanding debt for VANI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.11
ROIC/WACCN/A
WACCN/A
VANI Yearly LT Debt VS Equity VS FCFVANI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.30 indicates that VANI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.30, VANI is not doing good in the industry: 79.79% of the companies in the same industry are doing better.
A Quick Ratio of 1.30 indicates that VANI should not have too much problems paying its short term obligations.
VANI has a worse Quick ratio (1.30) than 64.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
VANI Yearly Current Assets VS Current LiabilitesVANI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.00% over the past year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, VANI will show a very negative growth in Earnings Per Share. The EPS will decrease by -19.85% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.84%
EPS Next 2Y2.45%
EPS Next 3Y-3.62%
EPS Next 5Y-19.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VANI Yearly Revenue VS EstimatesVANI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2029 2030 2031 50M 100M 150M 200M
VANI Yearly EPS VS EstimatesVANI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VANI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VANI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VANI Price Earnings VS Forward Price EarningsVANI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VANI Per share dataVANI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

A cheap valuation may be justified as VANI's earnings are expected to decrease with -3.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.45%
EPS Next 3Y-3.62%

More info and screens

0

5. Dividend

5.1 Amount

VANI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIVANI MEDICAL INC

NASDAQ:VANI (12/2/2025, 4:30:02 PM)

1.34

+0.01 (+0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/bmo
Earnings (Next)03-30 2026-03-30
Inst Owners6.84%
Inst Owner Change-3.33%
Ins Owners48.99%
Ins Owner Change0%
Market Cap97.75M
Revenue(TTM)N/A
Net Income(TTM)-25.54M
Analysts82.5
Price Target5.1 (280.6%)
Short Float %0.82%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.18%
Min EPS beat(2)-17.65%
Max EPS beat(2)-2.71%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-17.65%
Max EPS beat(4)6.22%
EPS beat(8)6
Avg EPS beat(8)3.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 19.91
P/tB 19.91
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -88.35%
ROE -520.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 101.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z -7.11
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)158.98%
Cap/Depr(5y)139.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-0.84%
EPS Next 2Y2.45%
EPS Next 3Y-3.62%
EPS Next 5Y-19.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.57%
EBIT Next 3Y-15.98%
EBIT Next 5Y-39.03%
FCF growth 1Y7.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.92%
OCF growth 3YN/A
OCF growth 5YN/A

VIVANI MEDICAL INC / VANI FAQ

Can you provide the ChartMill fundamental rating for VIVANI MEDICAL INC?

ChartMill assigns a fundamental rating of 1 / 10 to VANI.


What is the valuation status of VIVANI MEDICAL INC (VANI) stock?

ChartMill assigns a valuation rating of 0 / 10 to VIVANI MEDICAL INC (VANI). This can be considered as Overvalued.


What is the profitability of VANI stock?

VIVANI MEDICAL INC (VANI) has a profitability rating of 0 / 10.